These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37830930)

  • 41. Prophylaxis of experimental moniliasis in quail. A comparison of ethylenediamine dihydriodide, Benlate, sodium propionate, gentian violet, and nystatin.
    Moorhead PD; Cross RF
    Avian Dis; 1972; 16(3):649-55. PubMed ID: 4556823
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pulsatilla decoction inhibits vulvovaginal Candida albicans proliferation and reduces inflammatory cytokine levels in vulvovaginal candidiasis mice].
    Xia D; Zhang M; Shi G; Xu Z; Wu D; Shao J; Wang T; Wang C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):153-7. PubMed ID: 26927371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Photodynamic therapy-mediated hypericin-loaded nanostructured lipid carriers against vulvovaginal candidiasis.
    Sato MR; Oshiro-Junior JA; Rodero CF; Boni FI; Araújo VHS; Bauab TM; Nicholas D; Callan JF; Chorilli M
    J Mycol Med; 2022 Nov; 32(4):101296. PubMed ID: 35660541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired neutrophil extracellular trap-forming capacity contributes to susceptibility to chronic vaginitis in a mouse model of vulvovaginal candidiasis.
    Yano J; Fidel PL
    Infect Immun; 2024 Mar; 92(3):e0035023. PubMed ID: 38289125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single-centre experience in Iran.
    Shokoohi G; Javidnia J; Mirhendi H; Rasekh-Jahromi A; Rezaei-Matehkolaei A; Ansari S; Maryami F; Goodarzi S; Romeo O
    Mycoses; 2021 Jul; 64(7):771-779. PubMed ID: 33811780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
    White DJ; Johnson EM; Warnock DW
    Genitourin Med; 1993 Apr; 69(2):112-4. PubMed ID: 8389723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System
    Spaggiari L; Sala A; Ardizzoni A; De Seta F; Singh DK; Gacser A; Blasi E; Pericolini E
    Microbiol Spectr; 2022 Jun; 10(3):e0269621. PubMed ID: 35499353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of vaginal antifungal formulations in vivo.
    McRipley RJ; Erhard PJ; Schwind RA; Whitney RR
    Postgrad Med J; 1979 Sep; 55(647):648-52. PubMed ID: 392480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study on classification and treatment of vulvovaginal candidiasis].
    Fan SR; Liu XP; Li JW; Xu AP; Liu M
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):532-5. PubMed ID: 16202291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
    Nagashima M; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida.
    Senthilganesh J; Kuppusamy S; Durairajan R; Subramaniyan SB; Veerappan A; Paramasivam N
    Med Mycol; 2022 Jan; 60(2):. PubMed ID: 34958385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy.
    Phillips NA; Rocktashel M; Merjanian L
    Drug Des Devel Ther; 2023; 17():363-367. PubMed ID: 36785761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis.
    Tapia CV; Hermosilla G; Fortes P; Alburquenque C; Bucarey S; Salinas H; Rodas PI; Díaz MC; Magne F
    Mycopathologia; 2017 Apr; 182(3-4):339-347. PubMed ID: 27882525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiofilm potential of Annona muricata L. ethanolic extract against multi-drug resistant Candida albicans.
    Campos LM; Silva TP; de Oliveira Lemos AS; Mendonça Diniz IO; Palazzi C; Novaes da Rocha V; de Freitas Araújo MG; Melo RCN; Fabri RL
    J Ethnopharmacol; 2023 Oct; 315():116682. PubMed ID: 37263318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
    Sherry L; Kean R; McKloud E; O'Donnell LE; Metcalfe R; Jones BL; Ramage G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison of the effectiveness of nystatin and kanesten in the treatment of vulvovaginal candidiasis].
    Kanadys W; Walkiewicz W; Drela M
    Wiad Lek; 1981 Apr; 34(8):663-5. PubMed ID: 7029920
    [No Abstract]   [Full Text] [Related]  

  • 57. Antifungal activity of propolis extract against yeasts isolated from vaginal exudates.
    Dalben-Dota KF; Faria MG; Bruschi ML; Pelloso SM; Lopes-Consolaro ME; Svidzinski TI
    J Altern Complement Med; 2010 Mar; 16(3):285-90. PubMed ID: 20192913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A stainless washable gentian violet specific for candida albicans (monilia) and other vaginal pathogens. One medication for all vaginal infections.
    Karnaky KJ
    Southwest Med; 1970 Dec; 51(12):271-2. PubMed ID: 5483953
    [No Abstract]   [Full Text] [Related]  

  • 59. Limosilactobacillus reuteri 29A Cell-Free Supernatant Antibiofilm and Antagonistic Effects in Murine Model of Vulvovaginal Candidiasis.
    Boahen A; Chew SY; Neela VK; Than LTL
    Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1681-1699. PubMed ID: 36881331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preclinical approaches in vulvovaginal candidiasis treatment with mucoadhesive thermoresponsive systems containing propolis.
    Bonfim AP; Sakita KM; Faria DR; Arita GS; Vendramini FAVR; Capoci IRG; Braga AG; Dos Santos RS; Bruschi ML; Becker TCA; de Oliveira Junior AG; Kioshima ÉS; de Souza Bonfim-Mendonça P; Svidzinski TIE
    PLoS One; 2020; 15(12):e0243197. PubMed ID: 33306677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.